双特异性抗体药物的研究进展  

Progress in research of bispecific antibody drugs

作　　者：郭婷婷 梁锦峰 聂磊 王海彬 白骅 

机构地区：[1]浙江海正药业股份有限公司,台州318000 [2]浙江省药品化妆品审评中心,杭州310012

出　　处：《中国新药杂志》2016年第5期518-523,共6页Chinese Journal of New Drugs

基　　金：国家"重大新药创制"科技重大专项(2013ZX09402101-001)

摘　　要：双特异性抗体是一类具有双功能的抗体分子,可以同时特异性结合2个不同的抗原。由于其特异性和双功能性,现已成为抗体工程领域的研究热点,在肿瘤免疫治疗及自身免疫病等领域中具有广阔的应用前景。目前,至少有30多种双特异性抗体药物处于临床研究阶段。本文主要对双特异性抗体药物的开发历史、分子结构和设计策略、作用机制等进行简要综述。Bispecific antibody is a kind of bi-functional protein composed of two different fragments and specifically binds to two different types of antigen. Due to its specificity and bi-function,bispecific antibody drugs have become a research focus in antibody engineering and have a wide application future in cancer immunotherapy and autoimmune disease. Nowadays,more than thirty kinds of bispecific antibody drugs are in clinical development. In this article we reviewed the recent progress in research of bispecific antibody drugs in development,design,and mechanism of action.

关 键 词：双特异性抗体 双价抗体 双功能抗体 

分 类 号：R979.5[医药卫生—药品]